Ivabradine Tablets 5mg, 7.5mg Tablet

What is Ivabradine Tablets 5mg, 7.5mg Tablet?

Ivabradine Tablets 5mg, 7.5mg contain ivabradine in oral tablet form and are available in 5 mg and 7.5 mg strengths. Ivabradine is a heart-rate-lowering medicine used in the management of certain cardiovascular conditions, including selected patients with chronic heart failure or stable angina, according to approved indications.

Uses / Indications

Ivabradine may be indicated for selected patients with:

• Chronic heart failure with reduced left ventricular systolic function
• Stable chronic angina in appropriate patients
• Conditions where reduction of elevated resting heart rate is clinically indicated

Use should follow the approved product information and appropriate healthcare professional assessment.

Benefits

• Helps reduce elevated heart rate.
• Provides selective heart-rate-lowering activity.
• May support management of symptoms in appropriate cardiovascular conditions.
• Available in 5 mg and 7.5 mg tablet strengths.
• Provides a convenient oral dosage form for pharmaceutical supply requirements.

Side Effects

Common Side Effects

Possible side effects may include:

• Temporary brightness or visual phenomena, such as increased brightness in the visual field
• Headache
• Dizziness
• Fatigue
• Changes in heart rate
• Increased blood pressure in some patients

Less Common or Serious Side Effects

Serious adverse effects may include excessive slowing of the heart rate, atrial fibrillation, conduction disturbances, or significant changes in heart rhythm. Severe dizziness, fainting, pronounced weakness, palpitations, or new or worsening cardiac symptoms require prompt medical assessment.

How Does It Work?

Ivabradine selectively inhibits the If current in the sinoatrial node, the natural pacemaker of the heart. This slows the rate of spontaneous pacemaker activity and reduces heart rate without directly reducing myocardial contractility.

Its heart-rate-lowering action can reduce cardiac workload and oxygen demand in appropriately selected patients.

Dosage Guidelines

• Take Ivabradine Tablets only according to the approved product information and healthcare professional guidance.
• The appropriate strength and dosing schedule depend on the indication, resting heart rate, clinical response, age, cardiac condition, and other medicines.
• Tablets should generally be taken with water and according to the prescribed schedule.
• Ivabradine is commonly administered with food when directed by the approved product information.
• Heart rate and cardiac rhythm may require monitoring during treatment.
• Do not change from 5 mg to 7.5 mg, or adjust the dose, without professional guidance.
• If a dose is missed, follow the approved product instructions rather than taking an additional dose.
• The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.
• If an overdose is suspected, seek immediate medical attention or contact an appropriate poison-control or emergency medical service.

When Not to Use

Ivabradine may not be appropriate in patients with:

• Known hypersensitivity to ivabradine or relevant product ingredients.
• Very low resting heart rate before treatment.
• Significant low blood pressure.
• Certain cardiac rhythm or conduction disorders.
• Acute myocardial infarction or unstable cardiovascular conditions where contraindicated.
• Severe liver impairment.
• Dependence on a cardiac pacemaker for maintaining heart rate.
• Concomitant use with potent CYP3A4 inhibitors where contraindicated.

The approved product information should be reviewed for complete contraindications.

Drug / Product Interactions

Important interactions may occur with:

• Potent CYP3A4 inhibitors
• Certain moderate CYP3A4 inhibitors
• Other medicines that lower heart rate
• Medicines that prolong the QT interval
• Certain calcium-channel blockers, such as verapamil or diltiazem
• Other cardiovascular medicines

A complete medication history should be reviewed by a qualified healthcare professional before treatment.

Safety Advice

• Heart rate and cardiac rhythm should be monitored as clinically appropriate.
• Report unusually slow heartbeat, fainting, dizziness, or palpitations.
• Visual brightness phenomena may occur, particularly during the early stages of treatment.
• Patients with rhythm disorders or low blood pressure require appropriate professional assessment.
• Avoid grapefruit or grapefruit juice if advised because it may affect ivabradine exposure.
• Pregnancy and breastfeeding considerations should be discussed with a qualified healthcare professional.
• Patients with liver or kidney impairment should inform their healthcare professional before treatment.
• Elderly patients may require individualized assessment and monitoring.

General Instructions

• Take the tablet exactly as directed.
• Follow the prescribed dosing schedule.
• Take the medicine with food when specified by the approved product information.
• Do not alter the strength or dose without professional guidance.
• Do not discontinue cardiovascular treatment without consulting a qualified healthcare professional.
• Keep the product out of reach of children.
• Do not use after the expiry date.
• Read the approved package insert before use.

Special Dietary / Lifestyle Tips

• Follow a heart-healthy diet appropriate for the individual’s cardiovascular condition.
• Limit excessive intake of alcohol.
• Avoid grapefruit or grapefruit juice if instructed by a healthcare professional.
• Maintain an appropriate level of physical activity according to medical advice.
• Follow recommended monitoring of blood pressure and heart rate.

Comparison with Other Treatments

Ivabradine reduces heart rate through a selective action on the sinoatrial node. Other cardiovascular medicines, including beta-blockers, calcium-channel blockers, ACE inhibitors, ARBs, and other treatments, act through different mechanisms and may be used depending on the underlying condition.

Treatment selection depends on the diagnosis, heart rate, blood pressure, cardiac function, other medicines, and individual clinical circumstances.

Precautions & Warnings

• Ivabradine can cause excessive slowing of the heart rate.
• Cardiac rhythm disturbances, including atrial fibrillation, may occur.
• Visual phenomena may affect some patients, particularly during the initial period of treatment.
• Use caution in patients with low blood pressure, conduction abnormalities, or significant cardiac rhythm disorders.
• Medicines that affect heart rate or ivabradine metabolism may increase the risk of adverse effects.
• Patients should report new or worsening palpitations, fainting, or significant changes in heart rate.
• Driving or operating machinery may require caution if visual symptoms occur.

Can I Use It With Other Medicines?

Generally Compatible With

Ivabradine may be prescribed with selected cardiovascular medicines when clinically appropriate and monitored by a qualified healthcare professional.

Use With Caution / Avoid

Particular caution may be required with:

• Strong CYP3A4 inhibitors
• Certain moderate CYP3A4 inhibitors
• Verapamil or diltiazem
• Other medicines that reduce heart rate
• Medicines that prolong the QT interval
• Other medicines affecting cardiac rhythm

Potential interactions should be reviewed against the approved product information.

Storage

Store according to the storage conditions stated on the approved product label and package insert.

• Keep the tablets in their original packaging.
• Protect the product from unsuitable environmental conditions as specified on the approved label.
• Keep out of reach and sight of children.
• Do not use after the stated expiry date.

Frequently Asked Questions

1. What is Ivabradine Tablets 5 mg and 7.5 mg used for?

Ivabradine is used in selected patients for cardiovascular conditions where reducing an elevated heart rate is clinically appropriate, including certain cases of chronic heart failure or stable angina.

2. What strengths are available in this product?

This product is available in 5 mg and 7.5 mg tablet strengths.

3. How does Ivabradine work?

Ivabradine selectively acts on the If current in the sinoatrial node to reduce the heart rate without directly reducing myocardial contractility.

4. Can Ivabradine affect vision?

Yes. Some patients may experience temporary visual brightness phenomena, particularly during the early period of treatment.

5. Can Ivabradine be taken with other heart medicines?

It may be combined with selected cardiovascular medicines when clinically appropriate. Certain medicines, particularly those that slow heart rate or affect ivabradine metabolism, require caution.

6. Can Ivabradine be used during pregnancy?

Ivabradine is generally not recommended during pregnancy. Pregnancy, breastfeeding, or plans to become pregnant should be discussed with a qualified healthcare professional.

7. Should Ivabradine be taken with food?

The approved product information may specify administration with food. Follow the instructions provided with the product and by the healthcare professional.

8. Is a pack insert available for this product?

Yes. The pack insert or leaflet is available upon request.